Ocugen
biopharmaceutical company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 9 annual filings
Revenue
$4.41M
Net Income
-$67.85M
Assets
$43.52M
EPS (diluted)
$-0.26
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001628280-26-014435Ocugen
Summary
Ocugen is a business[1].
Key Facts
- Ocugen is in the country of US[2].
- Ocugen's instance of is recorded as business[3].
- Ocugen's instance of is recorded as public company[4].
- Ocugen's headquarters location is recorded as Malvern[5].
- Ocugen's stock exchange is recorded as Nasdaq[6].
- Ocugen's industry is recorded as pharmaceutical industry[7].
- Ocugen's official website is recorded as http://ocugen.com/[8].
- Ocugen's legal form is recorded as XTIQ[9].
- Ocugen's social media followers is recorded as {'amount': '+18385'}[10].
- Ocugen's social media followers is recorded as {'amount': '+31423'}[11].
- Ocugen's social media followers is recorded as {'amount': '+41497'}[12].
Body
Operations
Ocugen's headquarters location is recorded as Malvern[5].
Industry
Ocugen's industry is recorded as pharmaceutical industry[7].
Ownership
Ocugen's stock exchange is recorded as Nasdaq[6].